Oncocyte Corporation (NASDAQ: OCX)
$3.40
+0.0400 ( +1.19% ) 28.9K
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.
Market Data
Open
$3.40
Previous close
$3.36
Volume
28.9K
Market cap
$43.97M
Day range
$3.26 - $3.40
52 week range
$2.08 - $4.64
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 18 | Apr 12, 2024 |
8-k | 8K-related | 14 | Apr 11, 2024 |
nt | Quarterly Reports | 1 | Apr 01, 2024 |
8-k | 8K-related | 15 | Jan 23, 2024 |
10-q | Quarterly Reports | 76 | Nov 09, 2023 |
8-k | 8K-related | 13 | Nov 09, 2023 |
4 | Insider transactions | 1 | Oct 12, 2023 |
8-k/a | 8K-related | 12 | Oct 10, 2023 |
8-k | 8K-related | 13 | Oct 05, 2023 |
8-k | 8K-related | 12 | Sep 20, 2023 |